Synthesis and structure-activity relationships of novel parenteral carbapenems, CS-023 (R-115685) and related compounds containing an amidine moiety

Journal of Antibiotics

Volumn 56, Issue 6, 2003, Pages 565-579

  Kawamoto, Isao ^a   Shimoji, Yasuo ^a   Kanno, Osamu ^a   Kojima, Katsuhiko ^a   Ishikawa, Katsuya ^a   Matsuyama, Emi ^a   Ashida, Yuka ^a   Shibayama, Takahiro ^a   Fukuoka, Takashi ^a   Ohya, Satoshi ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1BETA METHYLCARBAPENEM DERIVATIVE; AMIDINE; AMINOACYLASE; BIAPENEM; CILASTATIN; CS 023; ENZYME INHIBITOR; IMIPENEM; MEROPENEM; PYRROLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DESIGN; DRUG HALF LIFE; DRUG STABILITY; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION; URINARY EXCRETION;

EID: 0037588773     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.56.565     Document Type: Article

References (33)

1. Leanza, W. J.; K. J. Wildonger, T. W. Miller & B. G. Christensen: N-Acetimidoyl and N-formimidoyl-thienamycin derivatives: Antipseudomonal β-lactam antibiotics. J. Med. Chem. 22: 1435-1436, 1979
2. Birnbaum, J.; F. M. Kahan, H. Kropp & J. S. MacDonald: Carbapenems, a new class of beta-lactam antibiotics: Discovery and development of imipenem/cilastatin. Am. J. Med. 78 (Suppl. 6A): 3-21, 1985
3. Miyadera, T.; Y. Sugimura, T. Hashimoto, T. Tanaka, K. Iino, T. Shibata & S. Sugawara: Synthesis and in vitro activity of a new carbapenem, RS-533. J. Antibiotics 36: 1034-1039, 1983
4. Inoue, K.; Y. Hamana & S. Mitsuhashi: Antibacterial activity of panipenem, a new carbapenem antibiotic. Chemotherapy (Tokyo) 39 (Suppl. 3): 1-13, 1991
5. Naganuma, H.; H. Tokiwa, Y. Hirouchi, Y. Kawahara, J. Fukushige, M. Fukami, K. Hirota, S. Muramatsu, H. Takahagi, K. Inui, Y. Tanigawara, M. Yasuhara, R. Hori & S. Kuwahara: Nephroprotective effect and its mechanism of betamipron (1): Relationships of renal transport. Chemotherapy 39 (Suppl. 3): 166-177, 1991
6. Sunagawa, M.; H. Matsumura, T. Inoue, M. Fukasawa & M. Kato: A novel carbapenem antibiotic, SM-7338: Structure-activity relationships. J. Antibiotics 43: 519-532, 1990
7. Nagao, Y.; Y. Nagase, T. Kumagai, H. Matsunaga, T. Abe, O. Shimada, T. Hayashi & Y. Inoue: β-Lactams. 3. Asymmetric total synthesis of new non-natural 1b-methylcarbapenems exhibiting strong antimicrobial activities and stability against human renal dehydropeptidase-I. J. Org. Chem. 57: 4243-4249, 1992
8. Ubukata, K.; M. Hikida, M, Yoshida, K. Nishiki, Y. Furukawa, K. Tashiro, M. Konno & S. Mitsuhashi: In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I. Antimicrob. Agents Chemother. 34: 994-1000, 1990
9. Gill, C. J.; J. J. Jackson, L. S. Gerckens, B. A. Pelak, R. K. Thompson, J. G. Sundelof, H. Kropp & H. Rosen: In vivo activity and pharmacokinetic evaluation of a novel long-acting carbapenem antibiotic, MK-826 (L-749,345). Antimicrob. Agents Chemother. 42: 1996-2001, 1998
10. Shih, D. H.; L. Cama & B. G. Christensen: Synthetic carbapenem antibiotics I. 1β-Methyl carbapenem. Heterocycles 21: 29-40, 1984
11. Shih, D. H.; L. Cama & B. G. Christensen: Synthetic carbapenem antibiotics III. 1β-Methyl thienamycin. Tetrahedron Lett. 26: 587-590, 1985
12. Kawamoto, I.: 1β-Methylcarbapenem antibiotics. Drugs Fut. 23: 181-189, 1998
13. Iso, Y.; T. Irie, Y. Nishino, K. Motokawa & Y. Nishitani: A novel 1β-methyl carbapenem antibiotic, S-4661. Synthesis and structure-activity relationships of 2-(5-substituted pyrrolodin-3-ylthio)-1β-methyl-carbapenems. J. Antibiotics 49: 199-209, 1996
14. Sato, N. & F. Ohba: ER-35786. Drugs Future 21: 361-365, 1996
15. Ohba, F.; M. Nakamura-Kamijyo, N. Watanabe & K. Katsu: In vitro and in vivo antibacterial activities of ER-35786, a new antipseudomonal carbapenem. Antimicrob. Agents Chemother. 41: 298-307, 1997
16. Shin, K. J.; K. H. Yoo, D. J. Kim, S. W. Park, B. S. Ko, S. J. Lee, J. D. Huh & S. Y. Park: Synthesis and biological properties of new 1β-methyl carbapenems. Bioorg. Med. Chem. Lett. 8: 1607-1612, 1998
17. Imamura H.; N. Ohtake, A. Shimizu, H. Jona, H. Sato, R. Nagano, R. Ushijima, K. Yamada, T. Hashizume & H. Morishima: Structure-activity relationships of trans-3,5-disubstituted pyrrolidinylthio-1β-methyl-carbapenems. Part 1: J-111,347 and related compounds. Bioorg. Med. Chem. Lett. 10: 109-113, 2000
18. Quinn, J. P.; E. J. Dudek, C. A. DiVincenzo, D. A. Lucks & S. A. Lerner: Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections. J. Infect. Dis. 154: 289-294, 1986
19. Büscher, K.-H.; W. Cullman, W. Dick & W. Opferkuch: Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein. Antimicrob. Agents Chemother. 31: 703-708, 1987
20. Studemeister, A. E. & J. P. Quinn: Selective imipenem resistance in Pseudomonas aeruginosa associated with deminished outrer membrane permeability. Antimicrob. Agents Chemother. 32: 1267-1268, 1988
21. Trias, J. & H. Nikaido: Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 34: 52-57, 1990
22. Satake, S.; E. Yoshihara & T. Nakae: Diffusion of β-lactam antibiotics through liposome membrane reconstituted from purified porins of the outer membrane of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 34: 685-690, 1990
23. Fukuoka, T.; N. Masuda, T. Takenouchi, N. Sekine, M. Iijima & S. Ohya: Increase in susceptibility of Pseudomonas aeruginosa to carbapenem antibiotics in low-amino-acid media. Antimicrob. Agents Chemother. 35: 529-532, 1991
24. Kawamoto, I.; Y. Shimoji, O. Kanno, R. Endo, M. Miyauchi, K. Kojima, K. Ishikawa, M. Morimoto & S. Ohya: Synthesis and antibacterial activity of novel 1β-methyl carbapenems with cycloalkylamine moiety at the C-2 position. J. Antibiotics 54: 1080-1092, 2001
25. Ishikawa, K.; K. Kojima, M. Miyauchi, R. Endo, H. Yasuda & I. Kawamoto: Synthesis and structure-activity relationships of 1β-methylcarbapenems with quaternary ammonium side chains. J. Antibiotics 51: 757-770, 1998
26. Kawamoto, I.; R. Endo, K. Ishikawa, K. Kojima, M. Miyauchi & E. Nakayama: A convenient synthesis of versatile side-chain intermediates for carbapenem antibiotics. Synlett 575-577, 1995
27. Bernatowicz, M. S.; Y. Wu & G. R. Matsueda: Urethane protected derivatives of 1-guanylpyrazole for the mild efficient preparation of guanidines. Tetrahedron Lett. 34: 3389-3392, 1993
28. Lai, B. & A. K. Gangopadhyay: A practical synthesis of free and protected guanidino acids from amino acid. Tetrahedron Lett. 37: 2483-2486, 1996
29. Kawamoto, I.; Y. Shimoji, O. Kanno, K. Kojima, K. Ishikawa, T. Shibayama, S. Ohya & S. Kuwahara: R-115685, a novel parenteral carbapenem: Synthesis and structure-activity relationships. Abstracts of the 40th Interscience Conference on Antimicrobial Agent and Chemotherapy, F1229, 2000
30. Ohya, S.; T. Abe, C. Ishii, M. Kakuta, N. Masuda, Y. Utsui & S. Kuwahara: R-115685, a novel parenteral carbapenem: In vitro antibacterial activity. Abstracts of the 40th Interscience Conference on Antimicrobial Agent and Chemotherapy, F1230, 2000
31. Masuda, N.; T. Takenouchi, M. Kakuta, C. Ishii, E. Sakagawa, T. Abe, Y. Utsui, S. Ohya & S. Kuwahara: R-115685, a novel parenteral carbapenem: Mode of action and resistance mechanisms. Abstracts of the 40th Interscience Conference on Antimicrobial Agent and Chemotherapy, F1231, 2000
32. Ohya, S.; T. Fukuoka, H. Kawada, M. Kubota, A. Kitayama, T. Abe, H. Yasuda & S. Kuwahara: R-115685, a novel parenteral carbapenem: In vivo antibacterial activity. Abstracts of the 40th Interscience Conference on Antimicrobial Agent and Chemotherapy, F1232, 2000
33. Shibayama, T.; Y. Matsushita, N, Kikuchi, K, Kawai, T. Hirota & S. Kuwahara: R-115685, a novel parenteral carbapenem: Pharmacokinetics and metabolism in laboratory. Abstracts of the 40th Interscience Conference on Antimicrobial Agent and Chemotherapy, F1233,